Aging and DiseaseNeurosciencePeer-reviewed journal article
Lipidomic alterations in the cerebral cortex and white matter in sporadic Alzheimer's disease
Èlia ÒbisiD, Joaquím SoliD, Pol Andrés‐BenitoiD, Meritxell Martin‐GaríiD, Natàlia Mota‐MartorelliD, José Daniel Galo‐LiconaiD, Gerard Piñol‐RipolliD, Manuel Portero‐OtíniD, Isidró FerreriD, Mariona JovéiD, Reinald PamplonaiD
Abstract
AimsNon-targeted lipidomics analysis was conducted in post-mortem human frontal cortex area 8 (GM) and white matter of the frontal lobe centrum semi-ovale (WM) to identify lipidomes in middle-aged individuals with no neurofibrillary tangles and senile plaques, and cases at progressive stages of sporadic Alzheimers disease (sAD). MethodsLipidomic analysis using an LC-MS/MS platform was carried out in selected cases with suitable post-mortem lacking co-morbidities and concomitant brain pathologies. Complementary data were obtained using RT-qPCR and immunohistochemistry. ResultsThe WM shows an adaptive lipid phenotype resistant to lipid peroxidation, characterized by a lower fatty acid unsaturation, peroxidizability index, and higher ether lipid content than the GM. Changes in the lipidomic profile more marked in the WM than in GM occur in AD with disease progression. WM alterations are characterized by a decline in the content of branched fatty acid esters of hydroxy fatty acids (FAHFA), diacylglycerols (DG), triacylglycerols (TG), glycerophospholipids (GP) (especially ether lipids), and sphingolipids (especially sulfatides, ceramides, and glycosphingolipids). The GM acquires a fatty acid profile prone to peroxidation in sAD, while WM reinforces its peroxidation-resistant trait. Transcriptomic data point to additional defects of peroxisomal function. ConclusionsFour functional categories are associated with the different lipid classes affected in sAD: membrane structural composition, bioenergetics, antioxidant protection, and bioactive lipids, with deleterious consequences affecting both neurons and glial cells favoring disease progression.
- organism: human
- assay: metabolomics
- research focus: differential expression
- approach: statistical model
- Citations
- 28
- FWCI
- 4.97
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modeling the organizational heterogeneity of lipid-enriched microdomains in the neuronal membranes of gray and white matter of Alzheimer brain: A computational lipidomics study
Sruthi Peesapati, Sandipan Chakraborty·bioRxiv·Feb 18, 2026
- Elucidating Molecular Features of White Matter Hyperintensities in Alzheimer’s Disease through Multimodal Imaging and SHAP Analysis
Claire F. Scott, Cody R. Marshall, … Jeffrey M. Spraggins·bioRxiv·Jun 20, 2026
- Shared lipidome and proteome signatures of frontotemporal lobar degeneration and Alzheimer's disease
Yohannes Abere Ambaw, Alissa L. Nana, … Robert V. Farese·bioRxiv·Jul 11, 2026
- Characterization of Brain-Derived Extracellular Vesicle Lipids in Alzheimer's Disease
Huaqi Su, Yepy H. Rustam, … Laura J. Vella·Journal of Extracellular VesiclesPeer-reviewed·May 1, 2021
- Integrated Lipidomics and Nitro-Fatty Acid Profiling Link Adipose Redox Imbalance to Alzheimer's Disease-Related Neurovascular Injury
Sukkum Ngullie Chang, Praveen Kumar Guttula, … Manas Ranjan Gartia·bioRxiv·May 18, 2026
- Reduced triacylglycerols and lipid droplets are associated with resilience to Alzheimers disease
Daan van der Vliet, Luuk E. de Vries, … Mario van der Stelt·Alzheimer s & DementiaPeer-reviewed·Feb 1, 2026